Skip to main content
SpringerLink
Log in

Skeletal alterations in women affected by obesity

  • Short Communication
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Obesity has always been considered a protective factor for the skeleton and for osteoporosis. However, new epidemiologic and clinical data have shown that high level of fat mass might be a risk factor for osteoporosis and fragility fractures. Further, increasing evidences seem to indicate that the different components of metabolic syndrome (i.e. hypertension, increased triglycerides, and reduced high-density lipoprotein cholesterol) are also potential risk factors for the development of low bone mineral density and osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hu FB (2003) Overweight and obesity in women: health risk and consequences. J Women Health (Larchmt) 12(2):163–172

    Article  Google Scholar 

  2. McTigue K, Larosn JC et al (2006) Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 296(1):79–86

    Article  PubMed  CAS  Google Scholar 

  3. Rossner S (2002) Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 26:S2–S4

    Article  PubMed  Google Scholar 

  4. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795

    Article  Google Scholar 

  5. Jensen LB, Kollerup G et al (2001) Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation. JBMR 16(1):141–147

    Article  CAS  Google Scholar 

  6. Bonewald LF, Jhonson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42(4):606–615

    Article  PubMed  CAS  Google Scholar 

  7. Sawakami K, Robling AG et al (2006) The wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. JBC 281(33):23698–23711

    Article  CAS  Google Scholar 

  8. Premaor MO, Pilbrow L et al (2010) Obesity and fractures in postmenopausal women. JBMR 25(2):292–297

    Article  Google Scholar 

  9. Greco EA, Fornari R et al (2010) Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract 64(6):817–820

    Article  PubMed  CAS  Google Scholar 

  10. Kim KC, Shin DH et al (2010) Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 51(6):857–863

    Article  PubMed  CAS  Google Scholar 

  11. Cinti S (2001) The adipose organ: endocrine aspects and insights from transgenic models. Eat Weight Disord 6S:4–8

    Google Scholar 

  12. Helberg N, Wernstedt-Amsterholm I, Scherer PE (2008) The adipocyte as an endocrine cell. Endocrinol Metab Clin N Am 37(3):753–768

    Article  Google Scholar 

  13. Klein J, Perwitz N et al (2006) Adipose tissue as source and target of novel therapies. Trends Endocrinol Metab 17(1):26–32

    Article  PubMed  CAS  Google Scholar 

  14. Gomez-Ambrosi J, Rodriguez A et al (2008) The bone-adipose axis in obesity and weight loss. Obes Surg 18(9):1134–1143

    Article  PubMed  CAS  Google Scholar 

  15. Gimble JM, Zvonic S et al (2006) Playing with bone and fat. J Cellular Biochem 98:251–266

    Article  CAS  Google Scholar 

  16. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. JCEM 89(6):2548–2556

    PubMed  CAS  Google Scholar 

  17. Kiefer FW, Zeyda M et al (2008) Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149(3):1350–1357

    Article  PubMed  CAS  Google Scholar 

  18. Vendrell J, Broch M et al (2004) Resistin, adiponectin, ghrelin, leptin, and, inflammatory cytokines: relationship in obesity. Obes Res 12(6):962–971

    Article  PubMed  CAS  Google Scholar 

  19. Ye J, Keller JN (2010) Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging (Albany NY) 2(6):361–368

    CAS  Google Scholar 

  20. Calder PC, Ahluwalia N et al (2011) Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 106:S5–S78

    Article  PubMed  CAS  Google Scholar 

  21. Greco EA, Francomano D et al (2013) Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes 4(2):31–39

    Article  PubMed  Google Scholar 

  22. Wortsman J, Matsuoka LY et al (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690–693

    PubMed  CAS  Google Scholar 

  23. Earthman CP, Beckman LM et al (2012) The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes 36(3):387–396

    Article  CAS  Google Scholar 

  24. Bellia A, Garcovich G et al (2013) Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 8(1):33–40

    Google Scholar 

  25. Ferron M, McKee MD et al (2012) Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50(2):568–575

    Article  PubMed  CAS  Google Scholar 

  26. Migliaccio S, Greco EA et al (2011) Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes 4:273–282

    Article  PubMed  Google Scholar 

  27. Vilarrasa N, Vendrell J et al (2010) Is plasma 25(OH)D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38(2):235–242

    Article  PubMed  CAS  Google Scholar 

  28. Lamendola CA, Ariel D et al (2012) Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 95(5):1055–1059

    Article  PubMed  CAS  Google Scholar 

  29. Albala C, Yáñez M et al (1996) Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 20(11):1027–1032

    PubMed  CAS  Google Scholar 

  30. Wardlaw GM (1996) Putting body weight and osteoporosis into perspective. Am J Clin Nutr 63(3 Suppl):433S–436S

    PubMed  CAS  Google Scholar 

  31. Harford KA, Reynolds CM et al (2011) Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc 70(4):408–417

    Article  PubMed  CAS  Google Scholar 

  32. Sell H, Habich C, Eckel J (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8(12):709–716

    Google Scholar 

  33. Gimble JM, Nuttall ME (2012) The relationship between adipose tissue and bone metabolism. Clin Biochem 45:874–879

    Article  PubMed  CAS  Google Scholar 

  34. Zhao LJ, Jiang H et al (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. JBMR 23(1):17–29

    Article  CAS  Google Scholar 

  35. Schautz B, Later W et al (2011) Increases in central fat mass and decreases in peripheral fat mass are associated with accelerated arterial stiffening in healthy adults: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 65(7):784–790

    Article  PubMed  CAS  Google Scholar 

  36. Barton M (2012) Childhood obesity: a life-long health risk. Acta Pharmacol Sin 33(2):189–193

    Article  PubMed  CAS  Google Scholar 

  37. Russell M, Mendes N et al (2010) Visceral fat is a negative predictor of bone density measures in obese adolescent girls. JCEM 95(3):1247–1255

    PubMed  CAS  Google Scholar 

  38. Zaidi M, Buettner C et al (2012) Minireview: the link between fat and bone: does mass beget mass? Endocrinology 153(5):2070–2075

    Article  PubMed  CAS  Google Scholar 

  39. Schwetz V, Pieber T, Obermayer-Pietsch B (2012) The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol 166(6):959–967

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Unit of Endocrinology, Department of Movement, Human and Health Sciences, University “Foro Italico” of Rome, Largo de Bosis 14, 00135, Rome, Italy

    Silvia Migliaccio & Luigi Di Luigi

  2. Section of Medical Pathophysiology, Endocrinology and Nutrition, Department of Experimental Medicine, University “Sapienza” of Rome, Rome, Italy

    Emanuela A. Greco, Rachele Fornari, Lorenzo M. Donini & Andrea Lenzi

Authors
  1. Silvia Migliaccio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuela A. Greco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rachele Fornari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lorenzo M. Donini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luigi Di Luigi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrea Lenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvia Migliaccio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Migliaccio, S., Greco, E.A., Fornari, R. et al. Skeletal alterations in women affected by obesity. Aging Clin Exp Res 25 (Suppl 1), 35–37 (2013). https://doi.org/10.1007/s40520-013-0090-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-013-0090-1

Keywords

Search

Navigation